Showing results (131-140 of 208) with videos related to

Sort By:
Pageof 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
Hypermethylation of 18S and 28S ribosomal DNAs predicts progression-free survival in patients with ovarian cancerMichael W Y Chan, Susan H Wei, Ping Wen, et al.
FEBS Letters|December 24, 2016
MicroRNA-335-5p and -3p synergize to inhibit estrogen receptor alpha expression and promote tamoxifen resistanceElizabeth C Martin, Adrienne K Conger, Thomas J Yan, et al.
Molecular Cancer Therapeutics|July 23, 2024
Targeting Ovarian Cancer Stem Cells by Dual Inhibition of the Long Noncoding RNA HOTAIR and Lysine Methyltransferase EZH2Weini Wang, Yanchi Zhou, Ji Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2018
An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA MutationsNicholas Pulliam, Fang Fang, Ali R Ozes, et al.
Oncology Reports|October 6, 2011
The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cellsLyndsay V Rhodes, Ashley M Nitschke, H Chris Segar, et al.
BMC Systems Biology|May 11, 2011
A modulated empirical Bayes model for identifying topological and temporal estrogen receptor α regulatory networks in breast cancerChangyu Shen, Yiwen Huang, Yunlong Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markersSusan H Wei, Chuan-Mu Chen, Gordon Strathdee, et al.
JCI Insight|March 10, 2025
SUV39H1 maintains cancer stem cell chromatin state and properties in glioblastomaChunying Li, Qiqi Xie, Sugata Ghosh, et al.
Experimental Cell Research|September 13, 2011
Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cellsLyndsay V Rhodes, Melyssa R Bratton, Yun Zhu, et al.
NPJ Genomic Medicine|December 2, 2024
Comparative transcriptomic, epigenomic and immunological analyses identify drivers of disparity in high-grade serous ovarian cancerHao Huang, Russel Keathley, Ujin Kim, et al.
Pageof 21